Thursday, the Centers for Disease Control and Prevention (CDC) announced the number of salmonella cases have jumped to 228 spreading to a total of 23 states.

The FDA still has no clue regarding the origin of the tainted tomatoes. Although 228 seems minute in comparison to the population of the United States, Americans should not have to worry about what they eat, at least when the meal of choice is veggies. That is why we pay taxes. So agencies like the FDA can ensure our safety against deadly diseases including salmonella.

Labels: PLBI, Salmonella Outbreak

Proton Laboratories Inc., (Other OTC: PLBI.PK), announced the formation of a partnership today with BW2 Asia, that according to the release will allow
BW2 to market Proton's functional water systems throughout Asia starting with the Philippines.

Despite a slow day in the market today on fairly significant news, PLBI shares have held most of the gains made last Friday on rather low volume.

PLBI currently dedicates its available resources towards the penetration of the following three areas:

The food processing industry;
Medical facilities; and
Agriculture industry, specifically organic agriculture

As the occurrences of bacterial outbreaks including Salmonella and Staph dominate the daily news in increasing fashion and the Green movement continues to build steam, the company's green solutions offer a timely value-proposition in its key markets and likely a great deal more.

A great deal of research of research has already been conducted both proving PLBI's specific functional water formulations and the overall efficacy of electrolyzed water in general to eliminate even the nastiest bacteria, at times quicker than dangerous chemicals such as chlorine and always less harmful to the environment.

Labels: PLBI, Proton Laboratories

Another major salmonella outbreak was recently announced just a little over two months after the outbreak in Southern Colorado.

Still our powerful government doesn’t have a solution that can prevent another one.

I am just appalled at our government’s inability to implement, enforce and most importantly ensure that Americans are protected from deadly bacteria. This past outbreak has affected 167 Americans in 17 states, hospitalized 23 people and taken the life of a 67 year-old cancer patient.

To me this is unacceptable. A cancer patient that was already battling for his life is now dead because his weak and battered immune system couldn’t fight against the intestinal bacteria that he contracted from eating pico de galo from a Mexican restaurant in Texas.

Companies like Sanyo, Proton Laboratories (PLBI.PK) and EAU Technologies (EAUI.OB) have viable green solutions to defend against deadly bacteria. Their technologies take water and re engineer it through a process called electrolysis. In turn their solutions, have efficacy rates as high as 99% in regards to killing bacteria that includes Salmonella, E. coli, Streptococcus, Staphylococcus, Campylobacter, MRSA and other threats to our air, water and food supplies.

So, if the aforementioned companies have developed a means to eliminate deadly bacteria with minimal or zero use of toxic chemicals, then what is taking our government so long to implement them into our agriculture system? Not only would it keep Americans out of hospitals, it would save farmers and distribution companies millions of dollars. And isn’t that one of the FDA’s main goals to help minimize the health risk to Americans?

This technology has the means to tackle a growing problem in the United States and it can be done with out chemicals and no residual effects to the taste or overall presentation of the produce. However, until our government can remove its head from its sphincter we will continue to see salmonella outbreaks continue for years to come.

Labels: EAU Technologies, EAUI, Electrolyzed Water, FDA, Green Chemistry, PLBI, Proton Laboratories, Proton Labs, Salmonella Outbreak, Sanyo

Friday's gains of 130.77% ($0.03) demonstrate that Proton Laboratories, although well below its all-time high share price of $2.49, is building some momentum in the market. The company is currently seeking financing of $1 Million with an aggregate line of equity of $6 Million in order to facilitate bringing their mister product to market.

In recent weeks, PLBI has announced results from Hill Top Research backing the efficacy of its electrolyzed water and its effects on MRSA (Staph) along with its licensed and proprietary cooling tower process that utilizes the company’s advanced electrolysis technology. As we hope for more news in coming weeks lets take a look at why now may be a most beneficial time to consider taking an ownership position in PLBI.

The company began trading back on January 14, 2004 at a price of $0.85. Within just a little over nine weeks, PLBI saw gains of 188%, hitting $2.45, just four cents below its all- time high. Since then, stock price has fallen dramatically, hitting as low as $0.013 on June 6, 2008 on volume of a measly 6,000. This decrease is attributable to the company’s first line of equity of $10 Million from EFUND SMALL CAP FUND II, LP that gave the equity line investor the ability to convert stock at a discounted rate, which ultimately diluted the value of the stock.

Friday’s gains are promising however, because although PLBI is trading at just $0.03, the market has taken notice of their technology and its benefits to our environment, a topic that is all over the news and on the top of presidential candidate’s agendas.

PLBI’s efforts now appear to be focused on securing financing for its mister product, which in return will give them the ability to expand operations and enter into additional markets of interest as their technology becomes recognized as a leading, affordable solution to a growing global problem.

If PLBI can't secure critical funding for its mister product, share price will likely continue to hover in the low penny range and potentially force the company to take on unfavorable equity financing to fund operations.

With this in mind, Proton Laboratories has several key hurdles to overcome before achieving potential greatness, but management is determined to fix them and doing so will be a huge help to their overall success. This being said, my recommendation is to keep a close eye on PLBI over the next few weeks because history tends to repeat itself and any positive news should boost the stock after Friday's surge.

Labels: 130%, PLBI, Presidential Candidate, Proton Laboratories

Proton Laboratories Inc. (OTCPK: PLBI) shares gained more than 130% Friday on volume of 70,000.

PLBI engages in the design, manufacture, marketing and sale of functional water systems in the United States.
The company has taken a simple but well-established process of electrolytic ion separation that results in the byproduct of functional water.

The term “functional” has been applied to many mediums thus far and refers to the added benefit aside from the products original intended purpose. The company has taken this concept and introduced it to water. Based upon this new classification, water processed through an electrolytic ion separation process gains properties that bring functionality to itself. Delivering a new medium that can eliminate various strains of bacteria, virus, fungi, spores or communicable diseases and drinking water with incomparable hydrating properties than any sport drink available today.

PLBI has been able to take this technology and apply it to a wide range of industries from agriculture to the medical field that has unprecedented beneficial impacts on humanity and the environment .

PLBI also formulates intellectual properties under licensing agreements, supplies consumer and commercial grade products, consults on various projects utilizing functional water, and educates researchers at prestigious universities on the benefits of functional electrolyzed water. The company was founded by the CEO and CFO Mr. Edward Alexander in 2000 and is based out of Alameda, California.

Labels: PLBI, Proton Laboratories

Did you know that Staph Infections kill more Americans on an annual basis than AIDS?

Staphylococcus aureus, often referred to as "MRSA" is now the most common cause of staph infections. The highly drug resistant bacterium affects more than half a million people in the U.S. alone and is quickly spreading out of its traditional breeding ground - hospitals - and into places like schools, locker rooms, tattoo parlors, and restaurants.

Infection Driving Demand

Recent Staph-related deaths have been well-documented by the media and are leading to heightened consumer awareness surrounding the dangers of the deadly bacteria. They have also driven increased demand for capable cleaning products.

Unfortunately, the majority of current topical cleaning solutions on the market today are comprised of either chemical or alcohol-based formulations. In addition to the obvious dangers associated with the use of hazardous and even 'low toxic" chemical formulations to eliminate bacteria, alcohol-based products are reported to have a number of significant drawbacks. Skin/eye damage, corrosion to various surfaces, ineffectiveness due to rapid evaporation and public health risks are a few.

In response to the growing need for a "Green" topical cleaning product tough enough to tackle even the world's nastiest bacteria, Proton Laboratories (OTCBB: PLBIE) has developed an electrolyzed water formulation that has been successfully proven to drastically reduce MRSA on hard surfaces by a world renowned third party.

The Green Solution To Staph Infection

Proton has taken a simple but well-established process of electrolytic ion separation, added new thinking to the process, and re-engineered the structure of water so that it is low in pH and high in oxidation-reduction. Thus yielding a powerful medium that can be used as a:

1. Communicable disease control medium for health care environments where staph infections through MRSA and MRSE;
2. Disinfecting solution for industries that requires a clean and safe work environment; and
   
3. A highly efficacious, safe and healing assisting medium for various aspects of wound care.

The technology, once mass produced, can be applied across a variety of potential application environments including: Home & Office, Personal and Commercial.

Don't Forget To Wash Your Hands!

The number one MRSA prevention method as identified by the CDC is "Wash your hands. Use soap and water or an alcohol-base hand sanitizer".

Public perception has changed. No longer are hand sanitizers only used in medical facilities. They are now ubiquitous and found everywhere from From Chick-Fil-A to your local health club. According to ACNielson, U.S. hand sanitizer sales grew by double digits from 2003 to 2007. While the market remains dominated by the Purell Brand with nearly $40M in 2006 sales, the many downfalls of alcohol-based products are driving demand for "greener" products.


You're not gonna drink that, are ya? The simple fact is this. If you chose to ingest enough of your typical alcohol-based hand sanitizer, you could eventually get drunk. From what I've read, leading brands contain between 60% and 70% alcohol, about twelve times more than a single beer!

While amusing for felons, there have also been reports on increased child poisonings related to the consumption of hand sanitizers. In addition, The American Association of Poison Control Centers has reported that the country's 61 poison centers reported 12,000 related cases in 2006.

Global Leader in Healthcare Product Testing Gives "Thumbs Up"

Today's new release announces that Hill Top Research recently conducted a successful efficacy test of the company's electrolyzed water on MRSA, ATCC 6538 (Methicillin Resistant Staphylacoccusaureus). With more than 60 years of experience, Hill Top is the self-proclaimed "worldwide leader in clinical research for personal care and health care products".

Independent verification by such as highly-esteemed source provides the company with high level of credibility and confidence that its product is a winner. Proton now aspires to market the electrolyzed water as an off-the-shelf consumer spray product that can be used in the reduction to MRSA ATCC 6538 levels.

Proton Labs plans to contract manufacturing capabilities for the product by Q4 2008. So, the next few months could get very interesting indeed if the company keeps the public abreast of developments in that regard.

Proton Laboratories may in fact hold the key to a green solution for the world's staph infection problem. As consumers worldwide increasingly arm themselves with products designed to fend off problems including staph infections, salmonella, listeria and E.coli, cleaning formulations that are both non-toxic and non alcohol-based, such as those offered by Proton should be in high demand.

With the stock trading right around its historical low, we feel that now is a great time to take a deeper look into the company given its recent achievements and future potential.

Labels: Hand Sanitizers, MRSA, OTCBB:PLBI, OTCBB:PLBIE, PLBI, PLBIE, Proton Laboratories, Proton Labs, Staph, Staph Infection

Fifty cases of Salmonella Litchfield are raising concern across the United States and Canada and have forced Dole and several other major cantaloupe distributors to recall products. The infected cantaloupe was exported from Agropecuaria Montelibano a Honduran company. The FDA reported a warning on March 22 initiating these recalls.

By utilizing technology from Proton Laboratories, these type of outbreaks could become a thing of the past, ultimately saving companies money from having to recall their products. News like this - as bad as it is - may be will help PLBI make a very attractive sales case as they begin to bring their product to market.

Here is some commentary straight from the corporate profile housed on the PLBI website. It gives a bit more information on how the company's technology could help out in the situation mentioned above.

"Today, there are frequent instances in which bacteria have caused massive and costly recalls to industry based upon bacterial strains such as E.coli, Salmonella and Lysteria. In the hospital environments, numerous situations of MRSA or Staph infections have caused ongoing concerns to the safety and welfare of hospital patients and caregivers.

Functional Electrolyzed Water provides a highly-efficacious medium to control and eradicate these concerns, at a minimal cost, while creating economic dividends resulting from the areas of microbial safety, potentially lower health care costs and insurance premiums. The reassurance in the ability of maintaining the economic viability of an organization or institution from reliable and efficacious, microbe-free environments and products cannot be underestimated."

BACTERIAL STRAIN	BACTERIAL LOAD	Contact Time
		10 Seconds	60 Seconds	300 Seconds
P. aeruginosa	6.1x107	<100	<100	<100
E.coli O157:H7	3.1x107	<100	<100	<100
S.sonnei	1.7x106	<100	<100	<100
S.enteridis	1.7x108	<100	<100	<100
V.parahaemoluticus	8.3x107	<100	<100	<100
MRSA	1.7x106	<100	<100	<100
S.pyogenes	3.2x107	<100	<100	<100
B.subtilis	4.0x107	not tested	2.6x103	<100
C.botulinum	8.1x106	2.6x103	<100	<100

"The benefits of Functional Electrolyzed Water are in its high rate of efficacy, safety to the worker and environment, non-ability of microbes to develop an immunity against its kill factor and cost efficiency. It promotes a new paradigm in our thinking for a wide array of industrial and medical challenges. Proton Laboratories also possesses a repertoire of proprietary processes and products, formulated with Functional Electrolyzed Water, which deliver exponentially-empowered efficacies of solutions needed in the maintenance of health and wellness."

Labels: PLBI, Proton Laboratories, Salmonella Outbreak